Обмороки как фактор риска внезапной сердечной смерти

Обмороки как фактор риска внезапной сердечной смерти

Автор: Тюрина Татьяна Венедиктовна

Журнал: Клиническая практика @clinpractice

Рубрика: Обзоры

Статья в выпуске: 4 (20), 2014 года.

Бесплатный доступ

Рассмотрена связь обмороков и риска внезапной сердечной смерти (ВСС) с характером основного заболевания. Представлены данные о связи обмороков и риска ВСС с механизмом развития синкопальных состояний. Даны критерии обмороков с высоким риском ВСС. Приведен алгоритм диагностики синкопальных состояний в соответствии с рекомендациями Европейского общества кардиологов (2009).

Внезапная сердечная смерть, обмороки, синкопальные состояния

Короткий адрес: https://sciup.org/14338503

IDR: 14338503

Список литературы Обмороки как фактор риска внезапной сердечной смерти

  • Soteriades E., Evans J., Larson M. et al. Incidence and prognosis of syncope. N Engl J Med 2002; 347:878-85.
  • Ungar A., Del Rosso A., Giada F. et al. Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study. Eur Heart J 2010; 31:2021-26.
  • Savage D., Corwin L., McGee D. et al. Epidemiologic features of isolated syncope: the Framingham Study. Stroke 1985; 16:626-29.
  • Silverstein M., Singer D., Mulley A. et al. Patients with syncope admitted to medical intensive care units. JAMA 1982; 248:1185-89.
  • Del Rosso A., Ungar A., Maggi R. et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart 2008; 94:1620-26.
  • Moss A., Zareba W., Hall W. Multicenter Automatic Defibrillator, Implantation Trial II Investigators et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-83.
  • Bardy G., Lee K., Mark D. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-37.
  • Singh S., Link M., Wang P. et al. Syncope in the patient with nonischemic dilated cardiomyopathy. Pacing Clin Electrophys 2004; 27:97-100.
  • Packer M., Bristow M., Cohn J. et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334:1349-55.
  • Zipes D., Camm A., Borggrefe M. et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-e346.
  • Fonarow G., Feliciano Z., Boyle N., et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter" defibrillator. Am J Cardiol. 2000;85:981-95.
  • Russo A., Verdino R., Schorr C. et al. Occurrence of implantable defibrillator events in patients with syncope and nonischemic dilated cardiomyopathy. Am J Cardiol 2001; 88:1444-46.
  • Maron B., McKenna W., Danielson G. et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42:1687-1713.
  • Spirito P., Seidman C., McKenna W. et al. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336:775-85.
  • Maron B. Hypertrophic cardiomyopathy systematic review. JAMA 2002; 287:1308-20.
  • Elliott P., Poloniecki J., Dickie S. et al. Sudden death in hypertrophic cardiomyopathy identification of high risk patients. J Am Coll Cardiol 2000; 36:2212-18.
  • Roger V., Tajik A., Reader G. et al. Effect of Doppler echocardiography on utilization of hemodynamic cardiac catheterization in the perioperative evaluation of aortic stenosis. Mayo Clinic Proc. 1996; 71:141-9.
  • Chizner M., Pearle D., de Leon A., et al. The natural history of aortic stenosis in adults. Am Heart J 1980; 99:419-24.
  • Moya A., Sutton R., Ammirati F. et al. Guidelines for the diagnosis and management of syncope (version 2009). The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J 2009; 30:2631-71.
  • Quinn J., McDermott D., Stiell I. et al. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med 2006; 47:448-454.
  • Brembilla-Perrot B., Suty-Selton C., Beurrier D. et al. Differences in mechanism and outcomes of syncope patients with coronary artery disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing. J Am Coll Cardiol 2004; 44:594-601.
  • Olshansky B., Poole J., Johnson G., et al. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. J Am Coll Cardiol 2008;51:1277-85.
  • Napolitano C., Priori S. The long QT syndrome: molecular and genetic aspects. In: Gussak I., Antzelevitch C. eds. Cardiac Repolarization. Totowa, NJ: Humana Press, 2003.
  • Priori S., Schwartz P., Napolitano C. et al. Risk stratification in the long QT syndrome. N Engl J Med 2003;348:1866-74.
  • Priori S., Napolitano C., Giordano U. et al. Brugada syndrome and sudden cardiac death in children. Lancet 2000;355:808-9.
  • Brugada J., Brugada R., Antzelevitch C., et al. Long-term follow up of individuals with the electrocardiographic pattern of right bundle branch block and ST segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-78.
  • Strickberger S., Benson D., Biaggioni I. et al. Evaluation of syncope: from the American Heart Association Сouncils on clinical cardiology, cardiovascular nursing, cardiovascular disease in the young, and stroke, and the quality of care and outcomes research interdisciplinary working group; and the American College of Cardiology Foundation in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 2006; 47:473-84.
  • Antzelevitch C. Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias. Pacing Clin Electrophysiol 2003; 26:2194-208.
  • Corrado D., Leoni L., Link M., et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;1 08: 3084-91.
  • Roguin A., Bomma C., Nasir K. et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004;43:1843-52.
  • Colman N., Nahm K., Ganzeboom K., et al. Epidemiology of reflex syncope. Clin Auton Res 2004 Oct;14 Suppl 1:9-17.
  • Blanc J., Benditt D. Structural cardiac and pulmonary causes of syncope. In: The evaluation and treatment of syncope. Futura, 2003.
  • Shibao C., Biaggioni I. Orthostatic hypotension and cardiovascular risk. Hypertension 2010;56:1042-4.
  • Fagard R., De Cort P. Orthostatic hypotension is a more robust predictor of cardiovascular events than night-time reverse dipping in elderly. Hypertension 2010;56:56-61.
  • Jones C., Loehr L., Franceschini N. et al. Orthostatic hypotension as a risk factor for incident heart failure the atherosclerosis risk in communities study. Hypertension 2012;59:913-8.
  • Naschitz J., Rosner I. Orthostatic hypotension: frame-work of the syndrome. Postgrad Med J 2007;83:568-74.
  • Eigenbrodt M., Rose K., Couper D. et al. Orthostatic hypotension as a risk factor for Stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke 2000;31:2307-13.
  • Rose K., Eigenbrodt M., Biga R. et al. Orthostatic hypotension predicts mortality in middle-aged adults. Circulation 2006;114:630-6.
  • Fedorowski A., Stavenow L., Hedblad B. et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malm` Preventive Project. Eur Heart J 2010; 31:85-91.
  • Milstein S., Buetikofer J., Lesser J. et al. Cardiac asystole: a manifestation of neutrally mediated hypotension bradycardia. J Am Coll Cardiol 1989; 14:1626-32.
  • Almquist A., Gornick C., Benson D. et al. Carotid sinus hypersensitivity: evaluation of the vasodepressor component. Ciculation 1985; 67:927-36.
  • Brignole M., Alboni P., Benditt D. et al. Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Europace 2004; 6:467-537.
  • Werf C., Hofman N., Tan H. et al. Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: The experience of a tertiary referral center in The Netherlands Heart Rhythm 2010; 7:1383-89.
  • Sarasin F., Hanusa B., Perneger T. et al. A risk score to predict arrhythmias in patients with unexplained syncope. Acad Emerg Med 2003; 10:1312-17.
  • Steinberg J., Beckman K., Greene H. et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and AVID substudy. Antiarrhythmics versus Implantable Defibrillators. J Cardiovasc Electrophysiol 2001; 12:996-1001.
  • Wehrens X., Vos M., Doevendans P. et al. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002; 137:981-92.
  • Antzelevitch C., Brugada P., Borggrefe M. et al. Brugada syndrome: report of the Second Consensus Conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111:659-70.
  • Giustetto C., Di Monte F., Wolpert C. et al. Short QT syndrome: clinical findings and diagnostic of therapeutic implications. Eur Heart J 2006; 27:2440-47.
  • Costantino G., Perego F., Dipaola F. et al. STePS Investigators. Short-and long-term prognosis of syncope, risk factors, and role of hospital admission: results from the STePS (Short-Term Prognosis of Syncope) study. J Am Coll Cardiol 2008; 51:276-283.
  • Martin T., Hanusa B., Kapoor W. Risk stratification of patients with syncope. Ann Emerg Med 1997; 29:459-66.
  • Colivicchi F., Ammirati F., Melina D. et al. OESIL (Osservatorio Epidemiologico sulla Sincope nel Lazio) Study Investigators. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J 2003; 24:811-19.
  • Sud S., Klein G., Skanes A. et al. Predicting the cause of syncope from clinical history in patients undergoing prolonged monitoring. Heart Rhythm 2009; 6:238-43.
  • Vardas P., Auricchio A., Blanc J., et al. European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2007; 28:2256-95.
  • Goldberger J., Cain M., Hohnloser S., et al. AHA/ACC Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from AHA Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 2008; 118:1497-518.
  • Epstein A., DiMarco J., Ellenbogen K. et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-e62.gal syncope.
  • Dhingra R., Denes P., Wu D. et al. The significance of second degree atrioventricular block and bundle branch block (Observations regarding site and type of block). Circulation. 1974; 49:638-46.
  • Englund A., Bergfeldt L., Rehnqvist N. et al. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope. J Am Coll Cardiol 1995; 26:1508-15.
  • Brignole M. Management of syncope. ESC Guidelines Desk reference (Compendium of ESC Guidelines) 2007; 279-286.
  • Pierre B., Fauchier L., Breard L. et al. Implantable loop recorder for recurrent syncope: influence of cardiac conduction abnormalities showing up on resting electro-cardiogram and of underlying cardiac disease on follow-up developments. Europace 2008; 10:477-81.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp